1. Home
  2. CHMI vs ARMP Comparison

CHMI vs ARMP Comparison

Compare CHMI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • ARMP
  • Stock Information
  • Founded
  • CHMI 2012
  • ARMP N/A
  • Country
  • CHMI United States
  • ARMP United States
  • Employees
  • CHMI N/A
  • ARMP N/A
  • Industry
  • CHMI Real Estate Investment Trusts
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CHMI Real Estate
  • ARMP Health Care
  • Exchange
  • CHMI Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • CHMI 92.0M
  • ARMP 80.0M
  • IPO Year
  • CHMI 2013
  • ARMP N/A
  • Fundamental
  • Price
  • CHMI $3.39
  • ARMP $2.08
  • Analyst Decision
  • CHMI Buy
  • ARMP Strong Buy
  • Analyst Count
  • CHMI 3
  • ARMP 1
  • Target Price
  • CHMI $5.00
  • ARMP $7.00
  • AVG Volume (30 Days)
  • CHMI 259.3K
  • ARMP 7.1K
  • Earning Date
  • CHMI 03-06-2025
  • ARMP 03-20-2025
  • Dividend Yield
  • CHMI 17.70%
  • ARMP N/A
  • EPS Growth
  • CHMI N/A
  • ARMP N/A
  • EPS
  • CHMI N/A
  • ARMP N/A
  • Revenue
  • CHMI N/A
  • ARMP $5,467,000.00
  • Revenue This Year
  • CHMI N/A
  • ARMP $23.87
  • Revenue Next Year
  • CHMI $27.78
  • ARMP N/A
  • P/E Ratio
  • CHMI N/A
  • ARMP N/A
  • Revenue Growth
  • CHMI N/A
  • ARMP 34.92
  • 52 Week Low
  • CHMI $2.50
  • ARMP $1.80
  • 52 Week High
  • CHMI $3.99
  • ARMP $4.48
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 71.05
  • ARMP 51.22
  • Support Level
  • CHMI $3.07
  • ARMP $1.97
  • Resistance Level
  • CHMI $3.52
  • ARMP $2.12
  • Average True Range (ATR)
  • CHMI 0.09
  • ARMP 0.11
  • MACD
  • CHMI 0.03
  • ARMP -0.00
  • Stochastic Oscillator
  • CHMI 78.95
  • ARMP 27.50

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: